NCT06968533View on ClinicalTrials.gov

ECG Low Ejection Fraction Detection and Guiding in AI Navigated Treatment Era

NAEnrolling by invitationINTERVENTIONAL
Enrollment

13,350

Participants

Timeline

Start Date

June 1, 2024

Primary Completion Date

June 1, 2027

Study Completion Date

June 1, 2027

Conditions
Heart FailureVentricular Dysfunction, LeftArtificial IntelligenceEarly DiagnosisAsymptomatic DiseasesCost-Benefit Analysis
Interventions
DIAGNOSTIC_TEST

AI-ECG guided diagnosis

Participants undergo screening using the AI-ECG system. Participants identified as medium- to high-risk for LV dysfunction (LVEF \<50%) are recommended for echocardiography to confirm the diagnosis and guide subsequent management.

Trial Locations (1)

11490

Tri-Service General Hospital, National Defense Medical Center, Taipei

All Listed Sponsors
lead

National Defense Medical Center, Taiwan

OTHER